These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure. Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635 [TBL] [Abstract][Full Text] [Related]
4. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload. Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure. Li J; Yousefi K; Ding W; Singh J; Shehadeh LA Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726 [TBL] [Abstract][Full Text] [Related]
7. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093 [TBL] [Abstract][Full Text] [Related]
8. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload. You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344 [TBL] [Abstract][Full Text] [Related]
9. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction. Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865 [TBL] [Abstract][Full Text] [Related]
10. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner. Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059 [TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload. Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781 [TBL] [Abstract][Full Text] [Related]
12. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947 [TBL] [Abstract][Full Text] [Related]
13. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763 [TBL] [Abstract][Full Text] [Related]
15. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007 [TBL] [Abstract][Full Text] [Related]
16. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload. Carnevale D; Cifelli G; Mascio G; Madonna M; Sbroggiò M; Perrino C; Persico MG; Frati G; Lembo G Circulation; 2011 Sep; 124(12):1337-50. PubMed ID: 21900081 [TBL] [Abstract][Full Text] [Related]
17. Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload. Bualeong T; Kebir S; Hof D; Goelz L; Graewe M; Ehrentraut SF; Knuefermann P; Baumgarten G; Meyer R; Ehrentraut H J Negat Results Biomed; 2016 Apr; 15():9. PubMed ID: 27109115 [TBL] [Abstract][Full Text] [Related]
18. O-ring-induced transverse aortic constriction (OTAC) is a new simple method to develop cardiac hypertrophy and heart failure in mice. Nakao Y; Aono J; Hamaguchi M; Takahashi K; Sakaue T; Inoue K; Ikeda S; Yamaguchi O Sci Rep; 2022 Jan; 12(1):85. PubMed ID: 34997065 [TBL] [Abstract][Full Text] [Related]
19. Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction. Abbadi D; Laroumanie F; Bizou M; Pozzo J; Daviaud D; Delage C; Calise D; Gaits-Iacovoni F; Dutaur M; Tortosa F; Renaud-Gabardos E; Douin-Echinard V; Prats AC; Roncalli J; Parini A; Pizzinat N Cardiovasc Res; 2018 Jan; 114(1):123-137. PubMed ID: 29136112 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]